High activity of human cytomegalovirus in patients with Sjögren's disease

dc.contributor.authorPantalone, Mattia Russel
dc.contributor.authorXu, Xinling
dc.contributor.authorAlmazán, Nerea Martín
dc.contributor.authorGerstner, Christina
dc.contributor.authorFischer, Marie
dc.contributor.authorKvarnström, Marika
dc.contributor.authorSöderberg-Nauclér, Cecilia
dc.contributor.authorWahren-Herlenius, Marie
dc.contributor.authorRahbar, Afsar
dc.contributor.organizationfi=InFLAMES Lippulaiva|en=InFLAMES Flagship|
dc.contributor.organizationfi=MediCity|en=MediCity|
dc.contributor.organization-code1.2.246.10.2458963.20.68445910604
dc.converis.publication-id499246645
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/499246645
dc.date.accessioned2025-08-28T02:48:14Z
dc.date.available2025-08-28T02:48:14Z
dc.description.abstract<p>Sjögren's disease (SD) is a chronic autoimmune disease characterized by immune-mediated damage to salivary and lacrimal glands. This study aimed to explore the potential link between SD and human cytomegalovirus (HCMV), by analyzing presence of HCMV proteins in salivary gland tissue specimens and prevalence of HCMV-specific antibodies in serum samples from SD patients and controls. HCMV-immediate early (IE) and late proteins (LA and pp65) were highly abundant in tissue specimens from SD patients (88.9 %, 69.2 %, 45.8 %, respectively), and less abundant in patients with Sicca symptoms without SD (70.5 %, 20.0 %, 12.5 %, respectively). Samples in the SD group were also positive at higher scores for the HCMV proteins than Sicca symptom patients without SD. IgM prevalence was higher in SD patients than in healthy controls (32.1 % vs. 13.4 %, P = 0.04) and HCMV-IgG titers were higher (P < 0.0001). Understanding the potential role of HCMV in SD pathogenesis may contribute to advancements in disease prevention and treatment.<br></p>
dc.identifier.eissn1521-7035
dc.identifier.jour-issn1521-6616
dc.identifier.olddbid209731
dc.identifier.oldhandle10024/192758
dc.identifier.urihttps://www.utupub.fi/handle/11111/49420
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S1521661625001202?via%3Dihub
dc.identifier.urnURN:NBN:fi-fe2025082792472
dc.language.isoen
dc.okm.affiliatedauthorNaucler, Cecilia
dc.okm.affiliatedauthorDataimport, MediCity
dc.okm.discipline3111 Biomedicineen_GB
dc.okm.discipline3111 Biolääketieteetfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherElsevier BV
dc.publisher.countryUnited Statesen_GB
dc.publisher.countryYhdysvallat (USA)fi_FI
dc.publisher.country-codeUS
dc.relation.articlenumber110545
dc.relation.doi10.1016/j.clim.2025.110545
dc.relation.ispartofjournalClinical Immunology
dc.relation.volume279
dc.source.identifierhttps://www.utupub.fi/handle/10024/192758
dc.titleHigh activity of human cytomegalovirus in patients with Sjögren's disease
dc.year.issued2025

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
Naucler_high_activity_2025.pdf
Size:
4.46 MB
Format:
Adobe Portable Document Format